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The information contained within DNA is vital to directing all biological 
processes. All organisms have repair mechanisms in place to repair DNA damage quickly 
and efficiently. Without these repair pathways, DNA can acquire harmful mutations that 
can compromise the survival of an organism. Studies of DNA repair in Drosophila 
melanogaster have focused on mutagen sensitive (mus) mutants, each of which contain a 
mutation that renders them incapable of performing DNA repair. Since a majority of 
these mus genes are unmapped, the goal of this project was to determine what genes in 
the Drosophila melanogaster genome are mus106 and mus108. Presence of each 
mutation was confirmed by conducting mutagen sensitivity assays on homozygous 
crosses. It was determined that the mus106 mutation is no longer present in its 
corresponding stock, but that the mus108 mutation is still present in its stock. After 
analyzing publically available genome data, we suggest potential candidate genes for 
mus106 and mus108 to be DNA Ligase 4 and XRCC1, respectively. Since XRCC1 has not 
been previously studied in Drosophila melanogaster, there are no known alleles of this 
gene.  However, we conducted additional mutagen sensitivity tests on a transposon and 
an RNAi stock designed to target reduction of XRCC1. The results from these 
experiments are inconclusive until XRCC1 knockdown is confirmed. Further 
characterization of mus108 to other mutagens is in progress to better understand what 
DNA repair pathway MUS108 is involved in. This work can help researchers learn more 





Table of Contents 
Abstract…………………………………………………………………………………..ii 
List of Tables…………………………………………………………………………….vi 
List of Illustrations……………………………………………………………………..vii 
Section 1: Introduction…………………………………………………………………..1 
1.1 DNA Repair…………………………………………………………………………...1 
1.2 Drosophila as a model system…………………………………………………………3 
1.3 Mutagen Sensitivity…..……………………………………………………………….4 
1.4 mus106………………………………………………………………………………...5 
1.5 mus108………………………………………………………………………………...6 
1.6 Characterization of mus106 and mus108……………………………………………...7 
Section 2: Materials and Methods………………………………………………………9 
2.1 Fly husbandry…………………………………………………………………..……...9 
2.2 Determining Mutagen Sensitivity……………………………………………………10 
2.3 Deficiency Mapping……………………………………………………………….…11 
2.4 Selection of Candidate Gene for mus108…………………………………………….13 
2.5 Sequencing XRCC1…………………………………………………………………..15 
2.6 XRCC1 Alignments………………………………………………………………….17 
2.7 RNAi Knockdown of XRCC1………………………………………………………..17 
iv 
 
2.8 mus108 Complementation Test (with transposon in XRCC1)………………………18 
2.9 Additional Characterization of mus108A1……………………………………………20 
Section 3: Results…………………………………………………………………….....21 
3.1 Determining Mutagen Sensitivity …………………………………………………...21 
3.2 Deficiency Mapping………………………………………………………………….22 
3.3 Prediction of Candidate Gene for mus108……………………..…………………….24 
3.4 Sequencing XRCC1…………………………………………………………………..27 
3.5 XRCC1 Alignments……………………………………………………….…………29 
3.6 RNAi Knockdown of XRCC1……………………………………………….……….31 
3.7 mus108 Complementation Test (with transposon in XRCC1)……………………….32 
Section 4: Discussion……….………………………………………………………...…33 
4.1 mus106……………………………………………………………………………….33 
4.2 mus108……………………………………………………………………………….36 
4.3 Proposal of a mus108 candidate gene………………………………………………..39 
4.4 Candidate Gene: XRCC1…………………………………………………………….40 
4.5 Alignment of XRCC1 Orthologs…………………………………………………….41 
4.6 RNAi Knockdown of XRCC1……………………………………………………….43 
4.7 mus108 Complementation Test (with transposon in XRCC1)………………………45 
v 
 
4.8 In Progress…………………………………………………………………………...46 



















List of Tables 
Table 1: PCR and Sequencing Primers………………………………………………….16 
Table 2: Abbreviated list of genes uncovered by the Df(1)JC70 deletion…………...25-27 
Table 3: Abbreviated list of genes between up and garnet………………………….35-36 
















List of Illustrations 
Figure 1: Cross to determine mutagen sensitivity……………………………………….11 
Figure 2: Genomic location of the deficiency used for mapping mus106………………13 
Figure 3: Genomic location of each deficiency used for mapping mus108……………..14 
Figure 4: Cross for RNAi Knockdown of XRCC1……………………………………....18 
Figure 5: Genomic location of XRCC1 gene, XRCC1 transcript, and PBacXRCC1 
element…………………………………………………………………………………...19 
Figure 6: Complementation cross (with transposon in XRCC1)………………………...20 
Figure 7: Sensitivity of mus106D1 flies to MMS………………………………………...21 
Figure 8: Sensitivity of mus108A1 flies to MMS………………………………………...22 
Figure 9: Sensitivity of mus106D1/Df(1)ED7217 flies to 0.08% MMS…………………23 
Figure 10: Sensitivity of mus108A1/Df flies to 0.08% MMS……………………………24 
Figure 11: Isolation of XRCC1 from mus108A1 males………………………………….28 
Figure 12: Alignment of XRCC1 orthologs……………………………………………..30 
Figure 13: Sensitivity of TRiP/GAL4 flies to 0.08% MMS……………………………..31 




Research Question: What genes in the Drosophila melanogaster genome are mus106 and 
mus108? 
Introduction 
1.1 DNA Repair 
The genomes of all living things are constantly exposed to numerous substances that have 
the potential to cause DNA damage. These sources of damage encompass both exogenous and 
endogenous elements. Exogenous sources, also called mutagens, include ultraviolet light (UV), 
ionizing radiation (IR), and environmental and chemical pollutants, while endogenous sources 
result from normal metabolic processes (Hakem 2008; Torgovnick 2015). Each of these agents 
creates a different type of damage which can cause problems like incorrect base pairing, single 
and double stranded breaks, and formation of DNA adducts (Hakem 2008; Torgovnick 2015). 
One example of a mutagen is the alkylating agent methyl methanesulfonate (MMS) which adds a 
methyl group to either adenine or guanine (Beranek 1990) and results in stalled replication forks 
(Lundin 2005). Damage that is left unrepaired can cause accumulation of harmful mutations that 
can affect the viability of an organism. To combat this, there are numerous DNA repair pathways 
that work to fix damaged DNA and maintain genomic integrity. The major eukaryotic repair 
pathways are non-homologous end-joining, homologous recombination, nucleotide excision 
repair, base excision repair, and single strand break repair (Hakem 2008). A deficiency in any 
protein involved in these repair pathways primes cells for apoptosis or retaining mutations that 
can trigger the development of cancer (Torgovnick 2015).  
There are several diseases in humans that develop as a result of deficiencies in crucial 
DNA repair components, such as xeroderma pigmentosum, spinocerebellar ataxia-26, and Bloom 
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Syndrome (Torgovnick 2015; O’Driscoll 2012; Hoch 2017). For example, spinocerebellar ataxia 
is caused by mutations in the X-ray repair cross complementing 1, known as XRCC1, gene. 
XRCC1 is specifically involved in two repair pathways: base excision repair and single-strand 
break repair, which are described more fully below. 
The Base Excision Repair (BER) pathway is most active in the G1 phase of the cell cycle 
and is responsible for fixing non-bulky lesions that result from oxidation, alkylation, and 
deamination damage (Chatterjee 2017; Lee 2019). Many genes involved in this pathway are 
highly conserved indicating the importance of maintaining this type of repair (Lee 2019). BER 
follows three main steps to repair damaged bases: recognition, excision, and religation. Damaged 
bases are recognized by a DNA glycosylase which cleaves one side of the phosphodiester bond 
to create an AP (apurinic/apyrimidinic) site (Chatterjee 2017; Lee 2019). This AP site is then 
recognized by AP endonuclease 1 (APE1) and breaks the bond to fully release the damaged base 
(Lee 2019). The size of the repair determines if short patch or long patch repair will follow. 
Short patch repair replaces a single nucleotide using polymerase beta and religates the break with 
ligase 3 and XRCC1 (Chatterjee 2017; Lee 2019). Long patch repair can replace 2 to 13 
nucleotides using polymerase gamma/epsilon and religates with ligase 1 and flap endonuclease 
(FEN1) (Chatterjee 2017; Lee 2019). 
 Single strand break repair (SSBR) is closely associated with the BER pathway but there 
are differences in the proteins involved. This repair pathway can be triggered by abasic sites, 
oxidative damage, or problems from the topoisomerase I (TopI) enzyme (Chatterjee 2017). 
Similarly to BER there are short and long patch repair pathways in SSBR. The short patch 
version follows identical to that of BER where APE1 recognizes single stranded damage. Long 
patch SSBR is initiated by interaction of PARP1 with the site of damage (Chatterjee 2017). The 
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ends of the break are processed by APE1, polynucleotide kinase 3’-phosphate (PNKP), and 
aprataxin (APTX) (Chatterjee 2017). FEN1 will then proceed to remove the 5’ end of the 
damaged base, resulting in a single strand break. Polymerases will fill in the required nucleotides 
and ligation is completed by ligase 1 with proliferating cell nuclear antigen (PCNA) and XRCC1 
(Chatterjee 2017). Single strand breaks induced by TopI mimic the long patch version of SSBR, 
but the end processing is completed by tyrosyl-DNA phosphodiesterase 1 (TDP1) to remove 
TopI from the DNA break (Chatterjee 2017).  
 
1.2 Drosophila as a model system 
  Scientists use model organisms to gain additional knowledge on processes like DNA 
repair. The fruit fly, also known as Drosophila melanogaster, has been an important model 
organism in the field of genetics. Fruit flies are incredibly useful because they are easy to 
genetically modify, easy to keep in a lab setting, have short life spans, and produce numerous 
offspring (Hales 2015). Many of the DNA repair pathways are conserved across a wide range of 
species, and in Drosophila these repair pathways include BER, SSBR, NER and DSBR 
(Sekelsky 2017). Additionally, an analysis that compared human disease genes from OMIM to 
the Drosophila genome found that 77% of the human disease genes evaluated contained a 
distinct D. melanogaster ortholog (Reiter 2001). For example, D. melanogaster contain a gene 
for Bloom syndrome helicase that is orthologous to the Bloom helicase found in humans, making 





1.3 Mutagen Sensitivity 
Researchers originally used DNA damaging agents to induce random mutations in fruit 
flies to study basic genetic concepts but later focused on how the mutations formed from various 
treatments (Sekelsky 2017). Thus, a series of genetic screens identified D. melanogaster mutants 
that are unable to properly perform DNA repair. The screens were conducted decades ago (Boyd 
1976; Boyd 1982; Gatti 1979; Oliveri 1989) however, as of 2017 only 14 of the 58 mutagen-
sensitivity (mus) genes underlying these DNA repair defects had been identified molecularly 
(Sekelsky 2017). The mutagen sensitivity genes were identified by screening for mutant flies that 
exhibited sensitivity to the DNA damaging agent MMS in a mutagen-sensitivity assay (Sekelsky 
2017). Briefly, a mutagen-sensitivity assay is conducted as follows: Flies with the mutation of 
interest are set up in a vial to mate and lay eggs. The same adults are moved to second vial to lay 
an additional round of eggs and are then discarded. Larvae are treated by exposure to either a 
control substance, usually water, or the damaging agent of interest, like MMS. The control 
substance and mutagen is added to the food when larvae are chewing through the food. The 
larvae defective in DNA repair will experience higher amounts of cell death when exposed to the 
damaging agent. The relative survival of mutagen treated flies compared to control treated flies 
will determine the sensitivity of the mutation being studied. Since the initial mutagen sensitivity 
screens were designed to identify as many mus genes as possible, most of the genes were only 
minimally characterized beyond noting sensitivity to MMS. It is important to match each mus 
line to a mutation in a particular gene to learn more about DNA repair pathways in general and 
why each line expresses mutagen sensitivity.  
To further our understanding of DNA repair pathways in D. melanogaster- and by 
extension, the DNA repair pathways in other organisms- the work described here aimed to study 
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the genes mus106 and mus108 in further detail. Both genes were selected for further study 
because the FlyBase records for each gene included unpublished mapping data (Laurencon 
2001), which increases the likelihood of successfully mapping the gene by narrowing the 
probable gene regions. Additionally, an allele of each gene is publicly available at the 
Bloomington Drosophila Stock Center, which is a repository of unique Drosophila stocks used 
by researchers around the world.   
The most recent reference with data on the mus106D1 and mus108A1 mutations is an 
unpublished, personal communication to FlyBase from Laurencon (2001) (Thurmond 2019). The 
data was part of a small-scale attempt to further map the genes using deficiency mapping. This 
process involves using chromosomes that contain a deficiency, or a deleted region of genes, to 
help identify the specific location of a gene of interest. The communication refers to another 
publication for the treatment protocol, but it is unclear how many replicates were tested for each 
condition. The communication also does not provide the raw or vial-level data for each cross and 
treatment. For both mutations, Laurencon (2001) provides data on the homozygous cross in 
addition to each deficiency cross at 0.08% MMS, 0.1% MMS, and a control. The data provides a 
great starting point to follow up on to further map mus106D1 and mus108A1.  
 
1.4 mus106 
The mus106 gene is X-linked and represented by one recessive allele: mus106D1 (Boyd 
1976; Hawley 1985; Boyd 1990). Females homozygous for the mutation are sterile (Boyd 1976; 
Boyd 1982; Gatti 1979). Data collected from Boyd (1976) showed that mus106 mutants exhibit a 
weak sensitivity to both MMS and gamma radiation, and do not exhibit sensitivity to nitrogen 
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mustard, AAF, or UV. In addition, mus106 flies are moderately sensitive to high doses of X-ray 
exposure (Oliveri 1990).  
Using recombination mapping, Boyd (1976) loosely assigned mus106 to be located near 
the forked gene. Later summary data roughly mapped mus106 to a region on the X chromosome 
corresponding to map positions 36-44 (Gatti 1979; Smith 1980). The most recent mapping data 
(unpublished) from Laurencon (2001) maps mus106 to be between the genes for up and garnet. 
The mus101 gene is also located within this region, however, complementation tests between 
mus101 and mus106 show they are not two alleles of the same gene (Boyd 1976; Laurencon 
2001). A complementation cross is useful to determine if two mus mutations are located within 
the same gene (two different alleles) or in two separate genes. This means that when mus101 and 
mus106 were crossed together, flies of the mus101/mus106 genotype did not exhibit sensitivity to 




The mus108 gene is also X-linked and represented by one recessive allele: mus108A1 
(Boyd 1976; Hawley 1985; Boyd 1990). Female homozygotes are sterile (Boyd 1976; Boyd 
1982; Gatti 1979). mus108A1 flies are sensitive to MMS, show reduced ability for DNA synthesis 
after exposure to AAF and exhibit a moderate sensitivity to high doses of X-ray exposure (Smith 
1980; Oliveri 1990; Boyd 1982). Additionally, mus108 mutant flies are neither sensitive to ether 
anesthesia nor gamma radiation (Gamo 1989). However, there are noticeable gaps in the 
available information for mus108. For example, there is no published data describing the level of 
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sensitivity that mus108 mutants exhibit when exposed to MMS. Likewise, it is unknown if 
mus108 mutants are sensitive to UV or nitrogen mustard (Smith 1980; Buendia 1998), and there 
is no published data on any complementation tests involving mus108. 
An interesting aspect of the mus108 mutation is that it suppresses the magnification of 
rDNA (rRNA-encoding genes) in male flies. This means when the number of rDNA tandem 
repeats are reduced, mus108 mutants are unable to revert to wild-type levels of rDNA (Hawley 
1985). These magnification events are blocked at both the pre-meiotic and meiotic stages 
(Hawley 1985). This phenotype has only been recorded in mus108 mutants.  
mus108 has been roughly mapped to a region on the X chromosome corresponding to the 
map position 10.8 (Smith 1980). Laurencon (2001) further mapped the mutation to be within the 
cytological region 4E1-4EF2.  
 
1.6 Characterization of mus106 and mus108 
 In addition to mapping the location of the mus mutations, it is also important to further 
characterize them to better understand their predicted role in disrupting critical DNA pathways. 
Different mutagens cause different types of DNA damage, which can influence the type of repair 
pathway that is triggered in a cell (Chatterjee 2017). To learn more about the repair pathways 
that both mutations are involved in, we conducted a sensitivity test with two mutagens that the 
mutations have not yet been tested against: hydroxyurea (HU) and camptothecin (CPT). 
 Hydroxyurea is a non-alkylating mutagen that has been used in treating certain cancer 
types and sickle cell anemia (Singh 2016). Depending on the concentration, length of exposure, 
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and cell sensitivity, exposure to HU can be cytotoxic. In general, it inhibits DNA synthesis which 
results in DNA damage, stops cytokinesis and produces oxidative stress (Singh 2016). 
Specifically, HU targets ribonucleotide reductase (RNR), the enzyme responsible for reducing 
ribonucleoside diphosphate to deoxyribonucleotide which is required for DNA replication and 
repair (Singh 2016). Cells will pause in S phase if there are not enough dNTP’s to continue 
synthesizing DNA. As DNA polymerase slows down, a replication checkpoint is activated, 
causing an increase in RNR production to generate more dNTP’s so that DNA synthesis can 
continue (Singh 2016). However, if the replication checkpoint is not activated, then replication 
forks will become unstable in the presence of HU and can collapse, cause strand breaks and 
oxidative stress, and lead to cell death.  
 Camptothecin is an alkaloid compound used in anticancer treatments by inducing DNA 
damage in rapidly dividing cancer cells (Mei 2019). CPT specifically inhibits TopI, an enzyme 
that helps to relieve DNA supercoiling as replication occurs by producing single strand breaks 
(SSBs) to do so. In normal circumstances, TopI will immediately release from DNA so the 
strand can be religated, but in the presence of CPT, TopI is trapped on the DNA preventing the 
religation step (Mei 2019). When this happens, a pathway is triggered so that TopI is degraded 
and the SSB is repaired through the single strand break repair (SSBR) pathway (Mei 2019). If 
the breaks are not repaired quickly enough, it can lead to the formation of double stranded breaks 






Materials and Methods 
2.1 Fly husbandry 
Fly stocks were obtained from the Bloomington Drosophila Stock Center (BDSC) at 
Indiana University. These stocks were: mus106D1/C(1)DX, y1 f1/Dp(1;Y)y+ (BDSC #2318); 
mus108A1/C(1)DX, y1 f1 (BDSC #1490); Df(1)ED7217, w1118 
P{w[+mW.Scer\FRT.hs3]=3'.RS5+3.3'}ED7217/FM7h (BDSC #8952); Df(1)JC70/FM7c 
(BDSC #944); Df(1)BSC823, w1118/Binsinscy (BDSC #27584); Df(1)ED6727, 
w1118 P{w[+mW.Scer\FRT.hs3]=3'.RS5+3.3'}ED6727/FM7h (BDSC #8956); 
w1118PBac{w[+mC]=WH}XRCC1f03685 (BDSC #18682); y1 v1; P{y[+t7.7] 
v[+t1.8]=TRiP.HMJ23251}attP40 (BDSC #61359); y1 w*; P{w[+mC]=tubP-GAL4}LL7/TM3, 
Sb1 Ser1 (BDSC #5138) and DGRP-59 (BDSC #28129). The FM7w stock was obtained from Jeff 
Sekelsky at the University of North Carolina at Chapel Hill. Each stock is referred to using the 
following abbreviations, listed in the same order as above: mus106D1, mus108A1, Df(1)ED7217, 
Df(1)JC70, Df(1)BSC823, Df(1)ED6727, PBacXRCC1, TRiP, GAL4, wild-type, and FM7w.  
All flies were maintained in bottles on standard corn syrup/soy food (Archon Scientific) 
in a 25°C incubator on a 12-hour dark; 12-hour light cycle. For each fly cross, stocks were 
placed in bottles ten days prior to virgining and cleared three to five days later to avoid 
overcrowding. Kimwipes were added to the bottles as needed to absorb moisture and provide 
newly-eclosed flies a solid surface to walk on. For each cross, virgin females of the appropriate 
genotype were collected across four days and kept in separate vials by day. On the following 




2.2 Determining Mutagen Sensitivity 
To determine mutagen sensitivity, crosses were set up in bottles each containing around 
20 virgin FM7w females and 15 mutagen sensitive males (mus106D1 or mus108A1) (Figure 1A). 
Ten days later, virgin females of the mus106D1/FM7w or mus108A1/FM7w genotype were 
collected for a total of four days. On the fifth day, crosses were set up into ten vials each with 
five virgin mus/FM7w females and five of the corresponding mutagen sensitive males. The vials 
were put through a mutagen sensitivity assay, which is described below: 
Ten vials were set up with five females and five males for each cross, creating Brood 1 
(Day zero). On Day three, the parents were flipped into new vials to create Brood 2. On Day 
four, each vial of Brood 1 was treated with 250µL of ddH2O. Brood 2 vials were cleared out on 
Day five and treated with 250µL of 0.08% or 0.1% MMS (Sigma) dissolved in water on Day six. 
Brood 1 flies were frozen on Day 14 and Brood 2 flies frozen on Day 17. Relative survival was 
calculated as the ratio of mutant to non-mutant flies in the mutagen-treated (Brood 2) vials, 
normalized to the same ratio in the control (Brood 1) vials. Only vials that contained 20 or more 
flies were used for relative survival calculations (as in Romero et al. 2016). A low relative 
survival value indicates strong sensitivity to the mutagen. Flies were scored depending on the sex 
and eye phenotype, resulting in four potential phenotypes: female with wild-type eyes, males 





Figure 1. Cross to determine mutagen sensitivity. A) Two step cross to determine mutagen 
sensitivity in homozygous mus mutants. Cross applies to mus106D1 as well. B) The eye 
phenotype and sex of the potential offspring that result in the mutagen sensitivity assay. Both 
mus crosses result in the same phenotypes.  
 
2.3 Deficiency Mapping 
Deficiency stocks were chosen based on unpublished data from Laurencon’s (2001) 





between the genes up and garnet. The deficiency Laurencon found to disrupt mus106 was 
originally sought. However, there was a difference in nomenclature on FlyBase, making it 
unclear which deficiency was being referred to. Upon gathering further information, it was later 
determined that Df(1)g was the deficiency originally used by Laurencon (green bar in Figure 2). 
In place of Df(1)g, the deficiency Df(1)ED6727 was chosen since it was smaller, covered the 
undefined region found in Df(1)g, and covered the area between up and garnet (Figure 2). For 
mapping mus108, one deficiency used by Laurencon (2001), Df(1)JC70, was obtained in 
addition to two other stocks. Df(1)ED6727 covers the undefined portion at the beginning of 
Df(1)JC70, and Df(1)BSC823 sits near the end of Df(1)JC70 covering the other undefined region 
(Figure 3). 
Five virgin females of deficiency stock Df(1)ED6727 were crossed to five mus106D1 
males in ten vials for two separate rounds. Five virgin females of the deficiency stocks 
Df(1)ED6727, Df(1)JC70, and Df(1)BSC823 were each crossed to five mus108A1 males in ten 
vials each. For comparison, five wild-type/FM7w females were crossed to five wild-type males in 
ten vials each. The MMS sensitivity assay was then conducted as described above in 
“Determining Mutagen Sensitivity”. 
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2.4 Selection of Candidate Gene for mus108  
FlyBase (Thurmond 2019) was used to determine the biological functions of all 
genes uncovered by Df(1)JC70 and a candidate gene was chosen from among these.  
 
2.5 Sequencing XRCC1 
DNA was extracted from a single mus108A1 male using the “Fly Squish protocol” 
as in Gloor et al. 1993. Forward and reverse XRCC1 PCR primers (Table 1; Integrated 
DNA Technologies) were designed using the FlyBase reference genome sequence 
(Thurmond 2019) and PCR was used to amplify the candidate gene, XRCC1. 
Optimization of PCR product was made by altering MgCl2 concentrations, type of 
polymerase enzyme, extension time, and annealing conditions. The following conditions 
produced the desired product: 1µL template DNA (derived from Fly Squish protocol 
above), 0.63µL dNTP (10mM each NTP; Promega), 0.63µL 50pmol/µL primer -72, 
0.63µL 50pmol/µL primer 2356a, 5µL 5x iProof (Bio-Rad) standard buffer, 0.75µL 
50mM MgCl2 (final concentration: 1.5mM), 16.13µL H2O, and 0.25µL iProof (Bio-Rad) 
high-fidelity DNA polymerase with an annealing temperature of 58.4°C and a one minute 
and 30 second extension time.  
 PCR samples were then run on 0.7% agarose gel with 1x TAE buffer solution. 
After optimizing PCR conditions to obtain the desired product, the DNA band was 
excised from the gel, then purified using the GeneJet Gel Extraction kit (Thermo 
Scientific) according to manufacturer instructions and eluted in 50µL ddH2O. The 
purified DNA and primers were then sent to Eurofins Genomics for Sanger sequencing. 
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Sequencing data was uploaded into the Sequencher program (Gene Codes Corporation) 
to align the samples to the wild-type XRCC1 sequence on FlyBase (Thurmond 2019). 
Any nucleotide differences between the reference sequence and the mus108A1 sequence 
were recorded along with the amino acid encoded by those nucleotides. All observed 
mutations were confirmed in a second fly prep and sequencing reaction. 
 
Primer Name Primer Sequence 
XRCC1 -72 5’-GGCGCAACTGTCGGCAAAG-3’ 
XRCC1 440 5’-GCGGTGGGAGATGAATGTCG-3’ 
XRCC1 502 5’-GCATGTAGTGGCTGCTGCGG-3’ 
XRCC1 1063 5’-GCACAATTCGTCTCCAGAG-3’ 
XRCC1 1260a 5’-CAGATAGTCTGCACACAGCC-5’ 
XRCC1 1632 5’-GATTGTGACACGCAGTTGG-3’ 
XRCC1 2192a 5’-CGAGCATATTCGATTAAC-3’ 
XRCC1 2356a 5’-GCTAGAGATGGACCATCG-3’ 
 
Table 1: PCR and Sequencing Primers. Primers are numbered according to their location 
with respect to the ATG of XRCC1 (-72 was 72 nucleotides before ATG). The lowercase 
‘a’ refers to the antisense strand used for reverse primers. Primers -72 and 2356a were 
used to isolate the full XRCC1 gene from mus108A1males. The remaining primers were 
distributed throughout the coding sequence to be used for Sanger sequencing. All primers 
were used for sequencing.  
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2.6 XRCC1 Alignments  
The following protein orthologs of XRCC1 were obtained from NCBI (National 
1988): Drosophila melanogaster (accession: NP_572217) , Danio rerio (accession: 
NP_0010033988), Xenopus tropicalis (accession:XP_031761618), Homo sapiens 
(accession:NP_006288.2), Mus musculus (accession:NP_033558). The sequences were 
aligned using default parameters in the Clustal Omega program (Sievers 2011), then 
viewed using GeneDoc (Nicholas 1997). 
 
2.7 RNAi Knockdown of XRCC1 
 Crosses were set up in ten vials each with five virgin TRiP females and five GAL4 
males (Figure 4). The same MMS sensitivity assay was conducted as described above in 
“Determining Mutagen Sensitivity”. The offspring showed the following phenotypic 
combinations: wild-type bristles and wild-type wings, stubble bristles and wild-type 
wings, wild-type bristles and curly wings, and stubble bristles and curly wings. Each 







Figure 4. Cross for RNAi knockdown of XRCC1. Cross between females with the RNAi 
construct balanced over CurlyO (balancer for the second chromosome) to males with 
GAL4 balanced over TM3, Sb, Ser (balancer for the third chromosome). +: wild-type; 
CyO: CurlyO; Sb: Stubble; Ser: Serrate. 
 
2.8 mus108 Complementation Test (with transposon in XRCC1) 
One tool available for exploring XRCC1 was a piggyBac stock that contains a 
transposable element located in the 5’UTR of the XRCC1 transcript (Figure 5). Crosses 
were set up in bottles each containing around 20 virgin PBacXRCC1 females and 15 
FM7w males (Figure 6). Ten days later, virgin females of the PBacXRCC1/FM7w 
genotype were collected for a total of four days. On the fifth day, crosses were set up into 
ten vials each with five virgin PBacXRCC1/FM7w females and five mus108A1 males. The 
same MMS sensitivity assay was conducted as described above in “Determining Mutagen 
19 
 
Sensitivity”. The offspring scored showed the same sex and phenotype combinations as 
seen in Figure 1.  
 
Figure 5. Genomic location of XRCC1 gene, XRCC1 transcript, and PBacXRCC1 
element. Blue arrowhead represents the gene and the direction in which it is transcribed. 
Gray regions on the left and right side of the XRCC1 transcript represent 5’ and 3’ UTRs, 
respectively. Tan regions represent exons and the lines in between tan sections represent 
introns. Blue triangle indicates the transgenic insertion site of the PBacXRCC1 





Figure 6. Complementation cross (with transposon in XRCC1). Two step cross to 
determine if mus108A1 is allelic to XRCC1.  
 
2.9 Additional Characterization of mus108A1 
To test the sensitivity of mus108A1 flies to two additional mutagens, the same 
cross set up and mutagen sensitivity assay was conducted as described in “Determining 
Mutagen Sensitivity” with differences in mutagens used. To test sensitivity to 
hydroxyurea, Brood 2 vials were treated with 250µL of 80mM hydroxyurea (Arcos) 
dissolved in water. To test sensitivity to camptothecin , a stock solution of 10mg/mL 
camptothecin (Arcos) in DMSO was made and diluted into a 1% Tween-20/5% ethanol 
solution to create a 50µM solution. Brood 1 vials were treated with 250µL of 1% Tween-





3.1 Determining Mutagen Sensitivity 
To verify the presence of a mutagen-sensitivity allele in the mus106D1 and 
mus108A1 stocks, an MMS sensitivity assay was conducted on homozygous individuals 
from each mus stock, and the average relative survival was calculated. Flies homozygous 
for mus106D1 showed an overall relative survival of 0.94 ±0.47 when exposed to 0.08% 
MMS, and an overall relative survival of 0.72 ±0.28 when exposed to 0.1% MMS (Figure 
7). Flies homozygous for mus108A1 showed an overall relative survival of 0.47 ±0.25 
when exposed to 0.08% MMS, and an overall relative survival of 0.26 ±0.13 when 
exposed to 0.1% MMS (Figure 8). Both mutagen sensitive stocks showed a decrease in 
relative survival with an increase in the MMS concentration. Overall, the mus108A1 flies 
showed a lower relative survival than the mus106D1 flies. 
 MMS concentration 
22 
 
Figure 7. Sensitivity of mus106D1 flies to MMS. Each point represents one vial. Large 
horizontal line is the mean, while the upper and lower lines show standard deviation. 
Graph includes two rounds of sensitivity data. Only vials with 20+ offspring were 
included.  
 
Figure 8. Sensitivity of mus108A1 flies to MMS. Each point represents one vial. Large 
horizontal line is the mean, while the upper and lower lines show standard deviation. 
Graph includes two rounds of sensitivity data. Only vials with 20+ flies were included.  
 
3.2 Deficiency Mapping 
Crosses were conducted between the mutagen sensitivity and deficiency stocks to 
narrow the location of each mus gene. Each deficiency stock contained a deletion of 
varying length and location on the X chromosome. The mutagen sensitivity assay was 




The overall relative survival value for mus106D1/Df(1)ED7217 was 1.60 ±0.83 
when exposed to 0.08% MMS (Figure 9). The overall relative survival values for 
mus108A1/Df(1)ED6727 was 0.99 ±0.38, mus108A1/Df(1)JC70 was 1.00 ±0.41, and 
mus108A1/Df(1)BSC823 was 0.95 ±0.53 when exposed to 0.08% MMS (Figure 10). The 
relative survival values for these deficiencies were very close and have a somewhat large 
standard deviation, although they are not as far spread as the mus106 deficiency data. An 
ANOVA test was performed on the relative survival values of the three mus108A1 
deficiencies and they were not found to be statistically different (p=0.9727). A cross of 
homozygous wild-type flies was also conducted as a comparison. The average relative 
survival for the wild-type cross was 0.97 ±0.17 when exposed to 0.08% MMS (Figure 
10). The mus108 deficiency data was compared to the wild-type data and still presented 
with no statistical difference (ANOVA; p=0.9941).  
 
Figure 9. Sensitivity of mus106D1/Df(1)ED7217 flies to 0.08% MMS. Large horizontal 
line is the mean, while the upper and lower lines show standard deviation. Graph includes 
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two rounds of sensitivity data. Each point represents one vial. Only vials with 20+ 
offspring were included.  
 
Figure 10. Sensitivity of mus108A1/Df flies to 0.08% MMS. Each point represents one 
vial. Large horizontal line is the mean, while the upper and lower lines show standard 
deviation. Only vials with 20+ offspring were included. There was no significant 
difference between the mean relative survival values of the three deficiencies (one-way 
ANOVA; p=0.9727), or when compared to the wild-type cross (one-way ANOVA; 
p=0.9941). 
 
3.3 Prediction of Candidate Gene for mus108 
Although the relative survival values for the three mus108A1 deficiency crosses 
were similarly close to 1, previous data suggested Df(1)JC70 as a possible location for 
mus108A1 (Laurencon 2001). A candidate gene was sought by investigating all genes 
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uncovered by Df(1)JC70 (Table 2). Three genes with a molecular function involved with 
DNA were Klf15 (Kruppel-like Factor 15), MCM3 (Minichromosome maintenance 3) 
and XRCC1 (X-ray repair cross complementing 1) which are involved in sequence-
specific DNA binding, DNA replication origin binding, and damaged DNA binding, 
respectively. 
Symbol Name Molecular Function 
Pp2C1 Protein phosphatase 2C Protein serine/threonine phosphatase activity 
Ctp Cut up 
Protein binding; Dynein light intermediate 
chain bindings 
Pdha 
Pyruvate dehydrogenase E1 
alpha subunit Pyruvate dehydrogenase activity 
CG7024 n/a Dehydrogenase activity 
Proc-R Proctolin receptor 
Proctolin receptor activity; Neuropeptide 
receptor activity 
Klf15 Kruppel-like Factor 15 
Sequence-specific DNA binding; DNA 
binding transcription factor activity 
CG6978 n/a Transmembrane transporter activity 
CG42594 n/a Potassium ion leak channel activity 
CG6927 n/a 
pH-gated chloride channel activity; 
Neurotransmitter receptor activity 
CG32772 n/a 
RNA polymerase II cis-regulatory region 
sequence specific DNA binding 
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phosphatase 4E Protein tyrosine phosphatase activity 
Ovo n/a 
RNA polymerase II cis-regulatory region 
sequence specific DNA binding 
CG32767 n/a 
RNA polymerase II cis-regulatory region 
sequence specific DNA binding 
Rg Rugose 




ATPase 13-related Proteasome binding; Ubiquitin binding 
Cdk7 Cyclin-dependent kinase 7 
Serine/threonine kinase activity; ATP 
binding 
snf Sans fille 
Protein of U1 & U2 snRNPs; Assemble 
spliceosome 
TrxT Thioredoxin T Disulfide oxidoreductase activity 
dhd Deadhead Disulfide oxidoreductase activity 
Rnp4F RNA-binding protein 4F mRNA binding 
Mcm3 
Minichromosome 




Rab guanyl-nucleotide exchange factor 
activity 
XRCC1 XRCC1 Damaged DNA binding 




potassium channel Photoreceptor activity; Calmodulin binding 
NAAT1 
Nutrient amino acid 
transporter 1 Transmembrane transporter activity 
 
Table 2. Abbreviated list of genes uncovered by the Df(1)JC70 deletion. All genes with 
an unknown molecular function (n = 24) were removed from this abbreviated list (See 
Table5 in Appendix for complete list of genes uncovered by Df(1)JC70). Genes are listed 
in the same order as they appear on the D. melanogaster X chromosome (Thurmond 
2019).  
 
3.4 Sequencing XRCC1 
 Prior to sequencing the mus108 candidate gene XRCC1, multiple PCR reactions 
were run to optimize gene amplification. Each set of reaction conditions was tested on 
two primer combinations (XRCC1 -72 with XRCC1 2192a and XRCC1 -72 with XRCC1 
2356a), which were predicted to produce amplicons of 2264 base pairs and 2428 base 
pairs, respectively. An initial PCR reaction was run using a touchdown protocol where 
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the annealing temperature decreased by 0.5°C each cycle, from 62°C to 54°C, and 
2.5mM MgCl2. This reaction produced faint or non-existent bands at the predicted 
amplicon sizes (data not shown). Optimization steps included using a PCR gradient to 
test multiple annealing temperatures, using Taq versus iProof polymerase, and using 
iProof HF versus GC buffers. Each of these conditions again produced extremely faint or 
non-existent bands (data not shown). A gradient PCR using the -72 and 2356a primers 
and a decreased MgCl2 concentration of 1.5mM produced a clearly defined band at an 
annealing temperature of 58.4°C (Figure 11). This band was excised and purified for 
sequencing using all of the primers listed in Table 1.  
 
Figure 11. Isolation of XRCC1 from mus108A1 males. Representative gel from attempts 
to optimize conditions for amplification of XRCC1. Lanes differ by annealing 
temperature. Lane one contains the O’GeneRuler DNA Ladder Mix (Thermo Scientific). 
Remaining lanes contain amplicons generated from mus108A1 males using primers -72 
and 2356a using conditions as described in Materials and Methods. Black box identifies 



































3.5 XRCC1 Alignments 
Following Sanger sequencing of the -72 and 2356a XRCC1 amplicon, the 
following missense mutations between the Drosophila melanogaster reference genome 
sequence and the mus108A1 sequence were identified: Q127K, Q195E, T196M, I203V, 
and S204T. Four silent mutations were also found (data not shown). To assess the degree 
of conservation for each of these residues, an alignment of XRCC1 protein sequences 







Figure 12. Alignment of XRCC1 orthologs. Highlighted regions indicate the domain regions in 
the human XRCC1 sequence as defined by (London 2015). Yellow= N-Terminal Domain; Blue= 
Linker 1 containing a Rev1-interacting region (RIR) and a Nuclear localization signal (NLS); 
Green= BRCTa domain; Pink= Linker 2 containing a phosphorylated FHA binding sequence 
(PFBS); Orange= BRCTb domain. Red stars indicate missense mutations found in the mus108A1 
sequences as noted in the text. Abbreviations are as follows: Dmel: Drosophila melanogaster; 
Drer: Danio rerio; Xtro: Xenopus tropicalis; Hsap: Homo sapiens; Mmus: Mus musculus.  
 
3.6 RNAi Knockdown of XRCC1 
 A cross between TRiP and GAL4 flies was conducted to determine if a knockdown of 
XRCC1 would express a mutagen sensitive phenotype after exposure to MMS. The overall 





Figure 13. Sensitivity of TRiP/GAL4 flies to 0.08% MMS. Each point represents one vial. Large 
horizontal line is the mean, while the upper and lower lines show standard deviation. Only vials 
with 20+ offspring were included. 
 
3.7 mus108 Complementation Test (with transposon in XRCC1) 
 To determine if XRCC1 is mus108A1, a complementation cross between PBacXRCC1, 
which contains a transposable element in the 5’ UTR of XRCC1, and mus108A1 was conducted. 
The overall relative survival for the PBacXRCC1 cross was 0.87 ±0.29 (Figure 14). However, it 
should be noted that these data were generated from only six vials (replicates) due to a lack of 
PBacXRCC1/FM7 females collected during the virgining process.  
 
 
Figure 14. Sensitivity of PBacXRCC1/mus108A1 flies to 0.08% MMS. Each point represents one 
vial. Large horizontal line is the mean, while the upper and lower lines show standard deviation. 





 Previous research has shown that the mus106D1 mutation is recessive, located on the X 
chromosome, and it is the only identified allele of mus106 (Boyd et al 1976; Hawley 1985). 
mus106D1 mutants exhibit sensitivity to MMS, gamma radiation, and X-rays (Boyd et al 1976; 
Oliveri 1990). The most recent data on mus106D1 was collected in 2001 in an attempt to further 
narrow down the location of the mutation (Laurencon). In that study, Laurencon identified one 
deficiency that failed to complement mus106D1 in MMS sensitivity assays at both 0.08% and 
0.1% MMS (2001). Now, 20 years later, before further mapping efforts were made, we needed to 
determine whether the mutant allele was still present in the stock by assessing sensitivity of 
mus106D1 homozygotes to MMS. As shown in Figure 7, the relative survival values were 0.94 
and 0.72 at 0.08% and 0.1% MMS, respectively. Even though mus106D1 is considered to have a 
weak sensitivity to MMS (as compared to other mus alleles (Boyd 1976)), an average relative 
survival of 0.94 at 0.08% MMS is much higher than would be expected for any “weak” 
sensitivity allele and is higher than the relative survival observed for mus106D1 when it was 
initially discovered (~20%) (Boyd 1976). An increase in MMS concentration however did 
further reduce relative survival (Figure 7), a feature which has been observed with most mus 
genes, including mus106 (Boyd 1976). 
Nonetheless, the current 0.08% MMS data has a relatively large standard deviation 
(±0.47), indicating many of the data points lie far from the average (Figure 7). For the 0.1% 
MMS data the standard deviation was only ±0.28 (Figure 7). With such a high standard deviation 
for the 0.08% MMS data, it is difficult to decide anything with certainty. It is unclear what 
caused such a large value given that both rounds of the assay were conducted by the same person 
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who followed the same protocol for every vial, including using the same commercially-prepared 
food, same Drosophila incubator, and same methods over a two-week span. 
The deficiency data for mus106D1 was also very spread out and had an average relative 
survival over 1 (Figure 9). A value of 1 represents that there is no difference in the ratio of 
mus106D1/Df(1)ED7217 flies to their balanced siblings between the MMS treatment and the 
control. If Laurencon’s prediction is correct and mus106D1 is between the genes for up and 
garnet, we would have seen much stronger sensitivity using the Df(1)ED7217 deficiency than we 
did. It is possible that mus106D1 simply does not lie within the deficiency Df(1)ED7217, 
considering the deficiency that Laurencon (2001) observed to disrupt mus106D1 (Df(1)g) was 
much longer (606,616 bp) than Df(1)ED7217 (180,238 bp) (Figure 2). However, it would not be 
expected for numerous data points in the deficiency cross to be above a relative survival of 2 or 
3. Relative survival values in this range would indicate mus106D1/Df(1)ED7217 flies are 
surviving in a greater ratio to their balanced siblings. This is not expected since flies with a 
deficiency have a region of their genome missing and typically do not survive better than those 
without such a deletion (Cook 2012). mus106D1 could be located within a different portion of the 
Df(1)g deficiency. We only pursued a deficiency that covered the beginning of Df(1)g because of 
the undefined start point in Df(1)g and because Df(1)ED7217 covered most of the genes between 
up and garnet. To confirm if mus106D1 is located within a different part of Df(1)g, additional 
deficiencies that cover the remaining portion of Df(1)g could be tested with mus106D1. 
 Based on the data collected on mus106, it is possible that the mus106D1 mutation is no 
longer present in the stock. It has been almost 20 years since this mus allele has been worked 
with (and 45 years since its original discovery) and it is possible that over time the mutation has 
been lost throughout numerous generations of maintaining the stock. A loss of the mutation 
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could explain why the homozygous cross and deficiency cross showed high average relative 
survival values. If the mutation is no longer present then DNA damage can be repaired properly, 
and the “mutant” flies would be surviving as well as their balanced siblings.  
Since Laurencon narrowed down the potential location of mus106 quite specifically and 
again determined that mus106 and mus101 are not alleles of the same gene, we investigated the 
molecular function of genes between up and garnet to choose a potential candidate gene (Table 
3) (Thurmond 2019). We propose DNA ligase 4 (DNAlig4) as a potential candidate gene for 
mus106D1. Out of the genes seen in Table 3, DNAlig4 is the only gene that is involved in DNA 
replication and repair, consistent with the observation that mutagen sensitivity occurs when 
proteins involved in DNA repair are defective or mutated.  
There is no way to confirm that the mus106D1 mutation discovered by Boyd (1976) was 
an allele of DNAlig4 if the mus106D1 mutation is truly gone, since we cannot perform 
complementation analysis with only one allele of mus106. However, we could do a series of 
mutagen sensitivity assays with alleles of the predicted candidate gene, DNAlig4, to see if it 
presents similar mutagen sensitivity to previous data seen on mus106. If so, this would further 
suggest that mus106 was DNAlig4. 
 
Symbol Name Molecular Function 
Up Upheld Tropomyosin binding; calcium ion binding  
Ndc80 Ndc80 Protein binding 
NFAT Nuclear factor of activated T-
cells 




DNAlig4 DNA ligase 4 DNA ligase (ATP) activity; DNA metabolism (response 
to IR) 
CG11164 n/a RNA-DNA hybrid ribonuclease activity 
CG15760 n/a localize integral component of organelle membrane 
CG11162 n/a C-4 methylsterol oxidase activity 
Nadsyn NAD synthetase NAD+ synthase activity; glutaminase activity 
Nna1 Nna1 carboxypeptidase metallocarboxypeptidase activity; zinc ion binding 
activity 
CG9941 n/a ubiquitin protein ligase activity; zinc ion binding 
G Garnet cargo adaptor activity 
 
Table 3. Abbreviated list of genes between up and garnet. All genes with an unknown molecular 
function (8) were removed from this abbreviated list (See Table 6 in Appendix for complete list 
of genes between up and garnet). Genes are listed in the same order as they appear on the D. 
melanogaster X chromosome (Thurmond 2019). 
 
4.2 mus108  
 Previous research has shown that the mus108A1 mutation is recessive, located on the X 
chromosome, and it is the only identified allele of mus108 (Boyd et al 1976; Hawley 1985). 
mus108A1 mutants exhibit sensitivity to MMS, AAF, and X-rays (Smith 1980; Oliveri 1990). 
Like mus106D1, the most recent data on mus108A1 was collected in 2001 in an attempt to further 
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narrow down the location of the mutation (Laurencon). In Laurencon’s study, four deficiencies 
failed to complement mus108A1 in an MMS sensitivity assay at both 0.08% and 0.1% (2001).  
Again, it was important to determine whether the mutant allele was still present in the 
stock by assessing sensitivity of mus108A1 homozygotes to MMS. mus108A1 flies exhibited a 
moderate level of sensitivity when exposed to 0.08% MMS, and an increase in MMS 
concentration to 0.1% further lowered relative survival. As shown in Figure 8, the relative 
survival values were 0.47 and 0.26 at 0.08% and 0.1% MMS, respectively. The standard 
deviation is also smaller (±0.25 at 0.08%; ±0.13 at 0.1%) than what was seen with the mus106 
data, which more confidently suggests that flies homozygous for mus108A1 are still sensitive to 
MMS. From the previous studies on mus108A1 there are no data that indicates what level of 
sensitivity this stock should show with exposure to MMS, only that it is sensitive (Smith & 
Dunsberry 1980). Although we cannot directly compare this to what was seen ~40 years ago, 
mus108A1 exhibits a dose-dependent response in sensitivity, and presents a moderate level of 
sensitivity based on what has been seen for other mus genes (Boyd 1976). For example, 
mus101D1 is exhibits a moderate level of sensitivity with a relative survival of about 20% at 
0.08% MMS (Boyd 1976).  
After confirming that the mus108A1 mutation was still present in the stock, we then used 
deficiency mapping to narrow the location of the gene within the fly genome. There were four 
deficiency stocks that Laurencon showed to disrupt mus108A1, but only one deficiency from this 
list was chosen to use in the deficiency mapping process: Df(1)JC70. The other three 
deficiencies either did not have stocks available (Df(1)ovoG6 and Df(1)ovoG7) or were only 
found in stocks that contained genomic deletions and duplications simultaneously (Df(1)A113). 
We used Df(1)JC70 as our starting point and chose two additional deficiencies (Df(1)ED6727 
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and Df(1)BSC823) that overlapped the undefined breakpoints of Df(1)JC70 to continue with the 
deficiency mapping. 
The rationale for our mapping assay using these deficiencies is as follows: Df(1)ED6727 
deletes a section before Df(1)JC70 begins up through the undefined start point of Df(1)JC70 
(Figure 3). If both Df(1)JC70 and Df(1)ED6727, for example, had shown a similar decrease in 
relative survival that was significantly different from Df(1)BSC823 – i.e. a failure to complement 
the mus108A1 allele – then we would have looked for a potential candidate gene within the 
deleted area that Df(1)JC70 and Df(1)ED6727 overlap. Df(1)BSC823 is a smaller deficiency that 
covers the undefined end region of Df(1)JC70, and the same strategy can be applied to this 
deficiency and Df(1)JC70. Finally, it was possible that mus108 is located in a region that is 
specific to only Df(1)JC70, in which case we would have expected to see decreased relative 
survival for this deficiency only. In particular, Laurencon saw ~50% survival with this 
deficiency, so we would have anticipated seeing similar values in our assay. 
However, there was no significant difference in relative survival for any of the 
deficiencies as compared to the wild type (ANOVA; p=0.9941) (Figure 10). The average relative 
survival values for the deficiencies were 0.99, 1.00, and 0.95 for Df(1)ED6727, Df(1)JC70, and 
Df(1)BSC823 respectively. This suggests that none of the deficiencies fail to complement 
mus108A1 (Figure 10).  
There was a large standard deviation seen in the deficiency crosses (Df(1)ED6727: ±0.38; 
Df(1)JC70: ±0.41; Df(1)BSC823: ±0.53). It is possible that the large standard deviations are a 
result of a modifier segregating in the stock. A modifier is a genetic variant that can modify the 
overall phenotype of the primary variant or mutation. This could cause a large standard deviation 
if all the X chromosomes were not identical, with the level of sensitivity changing between 
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variants of the X chromosome. One way to check for this would be to restart the mus108A1 stock 
from a single male, ensuring that all the X chromosomes in the stock are identical. Since we 
would not know which males carry the modifier, several mus108A1 lines could be set up, each 
starting from a single male. Mutagen sensitivity would be tested on each line and then compared. 
If the sensitivities differ between each line, it could suggest that the stock is indeed segregating 
certain sequences, whether that is mus108A1 or a modifier, which could possibly explain the large 
standard deviation seen in each deficiency cross.  
Another potential explanation for the lack of sensitivity seen in the deficiency crosses is 
that since the mus108A1 chromosome was originally created by exposure to a mutagen, the 
sensitivity we saw in the mus108A1/mus108A1 flies may be due, in part, to homozygosity for an 
additional mutation(s) on the chromosome.  
The data collected in this experiment does not lend support for choosing one deficiency 
over another for further study. Since Laurencon originally saw that Df(1)JC70 failed to 
complement mus108A1, we decided to pursue this deficiency as the target location to search for 
potential candidate genes. 
 
4.3 Proposal of a mus108 candidate gene 
The relative survival of the three deficiencies used to map mus108A1 had no significant 
difference in average relative survival, so we looked at the genes covered by Df(1)JC70, the 
deficiency that Laurencon originally saw to uncover the mus108 mutation. Looking at the 
molecular function of all the genes deleted by Df(1)JC70, we found three genes with a molecular 
function involved in DNA processes (Table 2). Kruppel-like Factor 15 (Klf15) is involved in 
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sequence-specific DNA binding. Minichromosome maintenance 3 (MCM3) forms part of the 
MCM2-7 hexamer, which aids specifically in 3’ to 5’ DNA helicase activity and DNA 
replication origin binding. X-ray repair cross complementing protein 1 (XRCC1) is involved in 
damaged DNA binding. Out of these three genes, we chose XRCC1 as our candidate gene to 
pursue mapping mus108 because this gene is specifically involved in repair of DNA damage, 
which is a key component of the mutagen sensitive classification.  
 
4.4 Candidate gene: XRCC1 
XRCC1 is a scaffold protein that aids in the recruitment and organization of various 
repair enzymes to carry out the complex processes to repair damaged DNA (London 2015/2020, 
Caldecott 2019). Scaffold proteins also help reduce the chance of toxic intermediates from being 
released during the repair process and causing additional damage (London 2015). The main 
repair pathway XRCC1 assists in is single strand break repair (SSBR), but it also supports 
interactions in the base-excision repair (BER) pathway and specific ligation issues (London 
2015/2020, Caldecott 2019). Notably, alkylation damage, caused by mutagens like MMS, is 
repaired by the BER pathway, making XRCC1 a stronger choice for our candidate gene (London 
2015/2020). 
The human XRCC1 ortholog is 633 amino acids long and contains several domains 
dedicated for specific molecular interactions (Caldecott 2019). Analysis of the human ortholog 
shows the domains include an N-terminal domain that binds to DNA polymerase Beta, a BRCT1 
domain which binds to poly(ADP-ribose) polymerase and dsDNA, and a C-terminal domain 
containing a BRCT2 domain that binds with Ligase 3 (London 2020/2015, Caldecott 2019). The 
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C-terminal region is not found in Drosophila melanogaster (London 2015). There are two linker 
sequences that sit between the domains. Linker 1 is ~150 amino acids long and contains a 
nuclear localization signal and a Rev1-interacting region (RIR) sequence that allows Rev-1 to 
bind and recruit additional polymerases (London 2015). Linker 2 is ~120 amino acids long and 
contains a motif that interacts with forkhead associated (FHA) domains used to recruit additional 
repair enzymes (London 2015). In humans, XRCC1 helps protect cells against damage caused by 
ionizing radiation, alkylation, and UV damage (London 2015). Several mammalian cell lines 
with mutations in XRCC1 have shown sensitivity to the mutagens MMS, CPT, HU, IR, and UV 
radiation, and ethyl methanesulfonate (EMS) (Caldecott 2019).  
 
4.5 Alignment of XRCC1 Orthologs 
The XRCC1 gene sequence in the mus108A1 stock was compared to the reference gene 
sequence on FlyBase to identify any mutations that exist in the mus108 candidate gene 
(Thurmond 2019). We identified five missense mutations, shown in Figure 12 and Table 4, and 
four silent mutations (data not shown). It was important to determine if any of the mutations 
were located in a highly conserved region of the gene. Mutations in a highly conserved area 
could be problematic to protein function because a region that is conserved across organisms 
indicates importance to the functionality of that protein. The first missense mutation in the 
mus108 XRCC1 sequence changes the 127th amino acid from glutamine to lysine, which is the 
conserved amino acid seen in each of the orthologs examined (Figure 12, Table 4). The first 
three mutations, at amino acids 127, 195, and 196, all change the chemical properties of the 
amino acid (e.g. Polar/uncharged amino acid to a hydrophobic amino acid). The last two 
mutations, at amino acids 203 and 204, change the amino acids, but still retain similar amino 
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acid properties (i.e. Changing from one hydrophobic amino acid to a different hydrophobic 
amino acid).  
An alignment of XRCC1 orthologs was created to visually assess regions of conservation 
in the gene. The mutation at amino acid 127 occurs in a conserved region of the N-terminal 
domain of XRCC1 (Figure 12).The remaining four missense mutations are in a less conserved 
region of the Linker 1 segment of the gene (Figure 12). None of the missense mutations stand out 
as being potentially problematic to the XRCC1 protein. The mutation at amino acid 127 would 
be promising if the amino acid were not changed to the conserved amino acid seen in the other 
orthologs. Even though amino acid changes at 195 and 196 change amino acid properties, they 
do not appear problematic because they are not located in a conserved region. However, it is 
possible that the cluster of mutations (two sets of adjacent mutations), which are only nine amino 
acids apart (195-204), could influence amino acid interactions and cause a problem with protein 
structure. Of course, this is just speculation and additional research would need to be conducted 









Amino Acid location 
in Drosophila 
Amino acid in XRCC1 reference 
sequence (amino acid property) 
Amino acid in mus108 XRCC1 
sequence (amino acid property)  
127 Glutamine (polar/uncharged) Lysine (positive charge) 
195 Glutamine (polar/uncharged) Glutamic acid (negative charge) 
196 Threonine (polar/uncharged) Methionine (hydrophobic) 
203 Isoleucine (hydrophobic) Valine (hydrophobic) 
204 Serine (polar/uncharged) Threonine (polar/uncharged) 
Table 4. Missense mutations in mus108 candidate gene, XRCC1. Five missense mutations seen in 
mus108 candidate gene when compared to wild-type reference sequence on FlyBase (Thurmond 
2019).  
 
4.6 RNAi Knockdown of XRCC1 
 An ideal experiment to determine if the candidate gene XRCC1 is mus108 would be to 
conduct a complementation test between alleles of both genes. If the alleles failed to complement 
each other, then that would suggest that mus108 is XRCC1. However, there are no true mutants 
of XRCC1 that exist currently (Thurmond 2019) so an RNAi line designed to knockdown XRCC1 
was used to determine if XRCC1 mutants are mutagen sensitive. Specifically, this RNAi line was 
created as part of the Transgenic RNAi Project (TRiP) to create a genome wide collection of 
RNAi stocks that can allow researchers to learn more about gene function across all tissue types 
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within Drosophila (Perkins 2015). The TRiP stock chosen for this experiment contains a hairpin 
that was designed to knock down XRCC1 under the control of the UAS promoter when 
expressed with a GAL4 line. The goal of this cross was to establish if XRCC1 mutants present a 
mutagen sensitive phenotype after exposure to MMS. Offspring that contain both the TRiP and 
GAL4 genotype together should knockdown XRCC1. If a reduced relative survival is seen, it may 
suggest XRCC1 is mutagen sensitive.  
The data for determining if a knockdown of XRCC1 presents a mutagen sensitive 
phenotype is inconclusive (Figure 13). Looking at just the average relative survival of 1.16 ± 
0.33, it suggests that a knockdown of XRCC1 does not present a mutagen sensitive phenotype. 
However, it is unknown if TRiP/GAL4 flies are actually knocking down XRCC1. The only way 
to confirm XRCC1 knockdown is to perform a RT-qPCR and compare levels of XRCC1 in those 
with TRiP/GAL4 to their siblings (those without TRiP or GAL4 or both). This is possible; 
however, the mutagen is applied at the larval stage, and the phenotypic markers used in this cross 
to differentiate the TRiP and GAL4 flies are seen only at the adult stage. Using the adult flies for 
the RT-qPCR is possible, however this is not ideal because it is not representative of the stage 
that we are assessing survival at (larval stage). Instead, two new stocks would need to be 
generated that each contained a larval phenotypic marker on the appropriate chromosome 
(chromosome 2 for the TRiP stock, chromosome 3 for the GAL4 stock) so that larvae with the 






4.7 mus108 Complementation Test (with transposon in XRCC1) 
An ideal experiment to determine if XRCC1 is mus108 would be to conduct a 
complementation test between alleles of the two genes. However, this is not currently possible 
since there are no true mutants of XRCC1 that exist. Similarly to the RNAi lines designed as part 
of TRiP, a transposon tool kit was created as another option for gene knockout in Drosophila 
melanogaster (Thibault 2004). FlyBase listed an available piggyBac stock that contained a 
known transposon insertion, derived from Lepidoptera, in the 5’ UTR of XRCC1 (Thibault 2004, 
Thurmond 2019).  
We conducted a cross between PBacXRCC1 and mus108A1 flies as a type of 
complementation test to determine if XRCC1 is mus108. The average relative survival for the 
PBacXRCC1 cross was 0.87 ±0.29 (Figure 14). On its own, the average relative survival suggests 
PBacXRCC1/mus108A1 flies exhibit a weak sensitivity to 0.08% MMS. However, only six vials 
were used for the cross due to difficulty obtaining balanced PBacXRCC1 flies from the initial 
cross (Figure 6) and half of the data points lie above a relative survival value of 1, making it 
difficult to conclude sensitivity.  
This is a similar situation to the RNAi knockdown experiment, where it is unknown if the 
piggyBac transposon is actually disrupting XRCC1. XRCC1 has not been studied in Drosophila, 
and this stock was created in addition to thousands of other piggyBac stocks (Thibault 2004, 
Thurmond 2019). The PBacXRCC1 stock has not been confirmed to disrupt XRCC1 gene 
expression but there are a couple ways to confirm this. The first option is to perform a RT-qPCR 
and compare levels of XRCC1 expression in PBacXRCC1 flies and wild-type flies. If 
pBacXRCC1 disrupts gene expression, we would expect there to be a decrease in the amount of 
XRCC1 RNA, meaning decreased levels of the protein, in the piggyBac flies. A second option is 
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to conduct a Northern blot to compare the size of the RNA transcript in the PBacXRCC1 flies to 
wild-type flies.  
 
4.8 In progress 
 Additional characterization of mus108A1 to other mutagens is currently in progress. The 
initial round of exposure to camptothecin and hydroxyurea failed due to the age of the food. We 
are confident the age of food initially used is the reason for this setback because Brood 1 of both 
assays were given older food and resulted in very few offspring. In the assay involving 
hydroxyurea as the mutagen, vial ten had newer food and resulted in many offspring compared to 
vial one of the same brood. Additionally, both Brood 2’s resulted in more offspring than the 
corresponding Brood 1, which should not be the case. Due to time constraints the crosses have 
been re-started but data collection will be completed after submission of this thesis.  
 
4.9 Future Directions 
This work has provided several options for continuing research on mus108A1. The first 
suggestion for future experiments involving mus108A1 would be to restart the stock from a single 
male fly to ensure that all of the X chromosomes are identical. If a modifier is segregating in the 
stock there could be multiple versions of the mus108A1 X chromosome, which could be skewing 
the data. Several mus108A1 lines would need to be started, each from a single male, and if 
sensitivities differ between each line it could suggest that the stock is segregating certain 
sequences, influencing the data obtained.  
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A second suggestion for experiments using mus108A1 is to conduct complementation 
analysis with other mus mutations on the X chromosome. It is assumed that previous researchers 
did complete a complementation analysis to ensure that mus108A1 is not an allele of another mus 
mutation, but there is no published complementation data for mus108A1. This would be a useful 
step to confirm that mus108A1 represents a separate complementation group (or not).  
A third suggestion is to confirm the RNAi knockdown of XRCC1 (utilizing the 
GAL4/UAS system) and confirm the transposon disruption of XRCC1 (PBacXRCC1). 
Confirmation of these constructs would allow future researchers to study XRCC1 in greater 
detail.  
A fourth suggestion for future experiments is to repeat the PBacXRCC1 transposon cross 
since this project failed to acquire enough replicates for the mutagen sensitivity assay. For the 
initial cross to get PBacXRCC1 balanced, more than three bottles should be set up in order to 
collect enough of the PBacXRCC1/FM7 females for the second part of the cross.  
Finally, future work should create mutant alleles of XRCC1 to conduct complementation 
crosses to mus108A1 and measure mutagen sensitivity. If there were true alleles of XRCC1, then it 
would eliminate the guess work of using non-validated RNAi or piggyBac experiments. While 
this is the better option to conduct a complementation test, it is not a task that can be completed 
quickly or easily, especially in the time frame for this project.  
 
4.10 Conclusion 
 Even though the pandemic disrupted our initial timeline, we conducted several 
experiments and reached several interesting conclusions. First, we determined that the mus106D1 
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allele is no longer present in the fly stock 45 years after its initial discovery. We analyzed data 
from previous researchers and utilized the publicly-available fly genome sequence to determine a 
likely candidate gene for mus106D1 to be DNA ligase 4. We determined that the mus108A1 
mutation is still present in the fly stock and analyzed previous research to determine a likely 
candidate gene for mus108A1 to be XRCC1. While we still need to validate the disruption of 
XRCC1 in the transposon and RNAi lines, we performed initial work with XRCC1, a gene that 
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Symbol Name Molecular Function 
Pp2C1 Protein phosphatase 2C 
Protein serine/threonine phosphatase 
activity 
Ctp Cut up 
Protein binding; Dynein light 
intermediate chain bindings 
Pdha 
Pyruvate dehydrogenase E1 alpha 
subunit Pyruvate dehydrogenase activity 
CG7024 n/a Dehydrogenase activity 
Proc-R Proctolin receptor 
Proctolin receptor activity; 
Neuropeptide receptor activity 
CG15472 n/a Unknown 
Klf15 Kruppel-like Factor 15 
Sequence-specific DNA binding; 
DNA binding transcription factor 
activity 
lncRNA:CR45515 Long non-coding RNA:CR45515 Unknown 
CG2871 n/a Unknown 
CG15471 n/a Unknown 
CG6978 n/a Transmembrane transporter activity 
CG2861 n/a Unknown 
lncRNA:CR45516 Long non-coding RNA:CR45516 Unknown 
CG12682 n/a Unknown 
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CG42594 n/a Potassium ion leak channel activity 
lncRNA:CR43495 n/a Unknown 
Boil Boilerman Unknown 
CG6927 n/a 
pH-gated chloride channel activity; 
Neurotransmitter receptor activity 
CG32772 n/a 
RNA polymerase II cis-regulatory 
region sequence specific DNA 
binding 
CG4041 n/a 





HpRNA:CR46342 Hairpin RNA:CR46342 Unknown 
CG44774 n/a Unknown 
Ptp4E Protein tyrosine phosphatase 4E Protein tyrosine phosphatase activity 
lncRNA:CR44833 Long non-coding RNA:CR44833 Unknown 
CG15468 n/a Unknown 
lncRNA:CR45792 n/a Unknown 
CG12680 n/a Unknown 
Ovo n/a 
RNA polymerase II cis-regulatory 





RNA polymerase II cis-regulatory 
region sequence specific DNA 
binding 
Rg Rugose 
Protein kinase binding; Protein kinase 
A binding 
CG15465 n/a Unknown 
Rpn13R 
Regulatory particle non-ATPase 13-
related 
Proteasome binding; Ubiquitin 
binding 
CG5062 n/a Unknown 
lncRNA:CR44834 n/a Unknown 
CG42749 n/a Unknown 
CG3323 n/a Unknown 
CG17764 n/a Unknown 
Cdk7 Cyclin-dependent kinase 7 
Serine/threonine kinase activity; ATP 
binding 
snf Sans fille 
Protein of U1 & U2 snRNPs; 
Assemble spliceosome 
TrxT Thioredoxin T Disulfide oxidoreductase activity 
dhd Deadhead Disulfide oxidoreductase activity 
CG4198 n/a Unknown 
CG15930 n/a Unknown 
Sas10 Something about silencing 10 Unknown 
Rnp4F RNA-binding protein 4F mRNA binding 
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Mcm3 Minichromosome maintenance 3 3-5' DNA helicase activity 
CG3309 n/a 
Rab guanyl-nucleotide exchange 
factor activity 
XRCC1 XRCC1 Damaged DNA binding 
CanB Calcineurin B Calcium ion binding 
SK 
Small conductance calcium-activated 
potassium channel 
Photoreceptor activity; Calmodulin 
binding 
NAAT1 Nutrient amino acid transporter 1 Transmembrane transporter activity 
 
Appendix A. List of all genes uncovered by the Df(1)JC70 deletion. Genes are listed in the same 












Symbol Name Molecular Function 
Up Upheld tropomyosin binding; calcium ion binding 
lncRNA:CR44654 long non-coding 
RNA:CR44654 
unknown 
CG11178 n/a unknown 
Ndc80 Ndc80 protein binding 
tth Toothrin unknown 
Tango2 Transport and golgi 
organization 2 
unknown 
CG2691 n/a unknown 
NFAT Nuclear factor of 
activated T-cells 
DNA-binding transcription factor activity; 
chromatin binding activity; RNA polymerase 
II cis-regulatory region sequence-specific 
DNA binding activity 
DNAlig4 DNA ligase 4 DNA ligase (ATP) activity; DNA metabolism 
(response to IR) 
CG11164 n/a RNA-DNA hybrid ribonuclease activity 
CG15760 n/a localize integral component of organelle 
membrane 
CG11162 n/a C-4 methylsterol oxidase activity 
CG12177 n/a unknown 
CG11158 n/a unknown 
Nadsyn NAD synthetase NAD+ synthase activity; glutaminase activity 
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Nna1 Nna1 carboxypeptidase metallocarboxypeptidase activity; zinc ion 
binding activity 
CG9941 n/a ubiquitin protein ligase activity; zinc ion 
binding 
mus101 mutagen-sensitive 101 unknown 
G Garnet cargo adaptor activity 
Grip91 Gamma-tubulin ring 
protein 91 
gamma-tubulin binding; microtubule minus-
end binding 
CG11134 n/a methylthioribulose 1-phosphate dehydratase 
activity 
CG11151 n/a unknown 
lncRNA:CR42861 long non-coding 
RNA:CR42861 
unknown 






CG32625 n/a unknown 
Rtc1 Rtc1 endoribonuclease activity 
Yp3 Yolk protein 3 carboxylic ester hydrolase activity 
rdgB retinal degeneration B ion binding; lipid & phospholipid transporter 
activity 
CtsB Cathepsin B cysteine-type endopeptidase activity 
59 
 
CG11103 n/a unknown 
inaE inactivation no 
afterpotential E 
lipoprotein lipase activity 
CG10993 n/a RNA binding 
CG10996 n/a carbohydrate binding; aldose 1-epimerase 
activity 
CG11095 n/a hydrolase activity 
Clic Chloride intracellular 
channel 
glutathione peroxidase activity; chloride 
channel activity; lipid binding 
 
Appendix B. List of all genes located between up and garnet. Genes are listed in the same order 
as they appear on FlyBase (Thurmond 2019). 
